Also, the bottom line with SQNM is that their technology works! The bad apples that mishandled the T21 test data were fired by the BOD, but the technology does WORK!
They have an estimated primary data collection date for a new T21 clinical trial in June of this year.
Bottom line is that there is no reason this should not be trading at the same levels it was before the data mishandling event - $15+
From a chart perspective, as well, next resistance = $15
Nice-Thanks for that information. I would have thought Sqnm would have fallen off more today. It held its ground. I think it could really start to head towards that 14 area to fill gap to the upside.
I never thought after this fell apart last year it would ever start to climb back up like this.
Market Data 
Markets 
AI
